Liver Guidance Archives | The British Society of Gastroenterology

Guidance

Alcohol care teams: reducing acute hospital admissions and improving quality of care

First published on 20 Nov 2018

Quality and Productivity: Proven Case Study Alcohol care teams: reducing acute hospital admissions and improving quality of care Provided by: The British Society of Gastroenterology and Bolton NHS Foundation Trust Publication type: Quality and productivity example Sharing good practice: What […]

Guidance

Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources

First published on 20 Nov 2018

EXECUTIVE SUMMARY Introduction Alcohol misuse and alcohol‐related problems, especially binge drinking and alcohol-related liver disease, are major public health concerns. Recently, much attention has focused on social policy and measures to reduce drinking. There is an additional need to provide […]

Guidance

Caution about the use of ulipristal acetate (Esmya)

First published on 05 Apr 2018

Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]

Guidance

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

First published on 21 Feb 2018

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Guidance

Treatment Recommendations for the management of patients with chronic HCV Infection

First published on 01 Feb 2016

These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]

Guidance

NICE guidance on Daclatasvir for treating chronic hepatitis C

First published on 25 Nov 2015

NICE technology appraisal guidance [TA364] Published date: November 2015

Guidance

NICE guidance on Ledipasvir–Sofosbuvir for treating chronic hepatitis C

First published on 25 Nov 2015

Guidance

NICE guidance on Ombitasvir–Paritaprevir–Ritonavir with or without Dasabuvir for treating chronic hepatitis C

First published on 25 Oct 2015

NICE technology appraisal guidance [TA365] Published date: November 2015

Guidance

NHS England service specification for Operational Delivery Networks for hepatitis C care in adults

First published on 22 Oct 2015

22nd October 2015 NHS England has published the service specification for Operational Delivery Networks (ODNs) for hepatitis C care in adults. The full document is available below. Many BSG members will have been involved in the set up processes to date […]